Citation: Kvi. Rolston et al., BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS, The American journal of medicine, 99(4), 1995, pp. 450-450
Authors:
PERCIVAL A
DRUSANO GL
BEAM TR
LOUIE T
PEGRAM PS
ROLSTON KVI
Citation: A. Percival et al., USES OF QUINOLONES FOR PROPHYLAXIS - PANEL DISCUSSION, Infectious diseases in clinical practice, 3, 1994, pp. 190000210-190000210
Authors:
RUBINSTEIN E
BERGAN T
BALL AP
BEAM TR
GOLDBERGER MJ
REINHART H
ROLSTON KVI
Citation: E. Rubinstein et al., FUTURE-ROLE AND USES OF QUINOLONES - PANEL DISCUSSION, Infectious diseases in clinical practice, 3, 1994, pp. 190000215-190000218
Authors:
DHOLAKIA N
ROLSTON KVI
HO DH
LEBLANC B
STREETER H
DVORAK T
BODEY GP
Citation: N. Dholakia et al., IN-VITRO ACTIVITY OF FK-037, A NOVEL PARENTERAL CEPHALOSPORIN, AGAINST BACTERIAL ISOLATES FROM NEUTROPENIC CANCER-PATIENTS, European journal of clinical microbiology & infectious diseases, 13(8), 1994, pp. 679-685
Authors:
DHOLAKIA N
ROLSTON KVI
HO IH
LEBLANC B
BODEY GP
Citation: N. Dholakia et al., SUSCEPTIBILITIES OF BACTERIAL ISOLATES FROM PATIENTS WITH CANCER TO LEVOFLOXACIN AND OTHER QUINOLONES, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 848-852
Citation: Kvi. Rolston et al., VANCOMYCIN VERSUS TEICOPLANIN FOR THE TREATMENT OF GRAM-POSITIVE BACTEREMIA IN PATIENTS WITH CANCER - REPLY, The Journal of infectious diseases, 170(5), 1994, pp. 1344-1345
Authors:
ROLSTON KVI
NGUYEN H
AMOS G
ELTING L
FAINSTEIN V
BODEY GP
Citation: Kvi. Rolston et al., A RANDOMIZED DOUBLE-BLIND TRIAL OF VANCOMYCIN VERSUS TEICOPLANIN FOR THE TREATMENT OF GRAM-POSITIVE BACTEREMIA IN PATIENTS WITH CANCER, The Journal of infectious diseases, 169(2), 1994, pp. 350-355
Citation: Kvi. Rolston et al., IN-VITRO ACTIVITIES OF ANTIMICROBIAL AGENTS AGAINST CLINICAL ISOLATESOF FLAVIMONAS-ORYZIHABITANS OBTAINED FROM PATIENTS WITH CANCER, Antimicrobial agents and chemotherapy, 37(11), 1993, pp. 2504-2505